A 30-year-old woman with a rare genetic developmental epileptic encephalopathy experienced major improvements in seizures, sleep, mood, language, and motor skills after starting CBD.
Epileptologists, families of patients with rare genetic epilepsies, and policymakers considering expanded CBD indications.
Beyond seizure reduction, CBD improved sleep, mood, language, and motor skills in a rare genetic epilepsy
What the researchers found
Off-label cannabidiol produced significant seizure frequency reduction in a patient with a rare genetic DEE not covered by current CBD indications. Beyond seizure control, the patient showed striking improvements in sleep quality, mood, behavior, language, and motor skills.
Why it matters
CBD is currently approved only for three specific epilepsy conditions. This case suggests potential benefit in other genetic epilepsies and highlights effects beyond seizure reduction.
The numbers in context
One 30-year-old patient. Relevant seizure frequency reduction. Improvements noted in sleep quality, mood, behavior, language, and motor skills.
How the study worked
Single case report of a 30-year-old female with a rare genetic developmental epileptic encephalopathy treated with off-label cannabidiol after drug-resistant seizures failed to respond to standard therapies.
What this study cannot tell us
Single case report cannot establish efficacy. Placebo effect and natural disease fluctuation cannot be ruled out.
How to read the evidence
Single case report provides the lowest level of clinical evidence, though the breadth of improvement is notable.
When this study was published
Published in 2024.
The bigger picture
Developmental epileptic encephalopathies beyond the three approved indications are a significant unmet medical need. If CBD benefits extend to other genetic DEEs, the approved indication list may need to expand.
Questions still open
- Should clinical trials of CBD be expanded to include other genetic developmental epileptic encephalopathies?
- What mechanism explains CBD's broad improvements beyond seizure reduction?
Common questions
Is CBD only approved for specific types of epilepsy?
Can CBD help with more than just seizures?
Read the original research
Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report.
Epilepsy & behavior reports, 27, 100687
Citation
Mannini, Elisa; Misirocchi, Francesco; Lazzari, Stefania; Balella, Giulia; Bottignole, Dario; Frapporti, Maddalena; Zinno, Lucia; Florindo, Irene; Parrino, Liborio; Mutti, Carlotta. (2024). Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report.. Epilepsy & behavior reports, 27, 100687. https://doi.org/10.1016/j.ebr.2024.100687
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk